Methotrexate Injection
Product Images NDC 16729-277

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 16729-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate Carton1

Methotrexate Carton1
This text appears to be a label for a medication called Methotrexate Injection, USP with a caution about it being a cytotoxic agent. It includes a 2D matrix, lot and expiration information, and mentions warnings on a package insert. The manufacturer's details are also provided.*
FDA Label Image

Methotrexate Carton2

Methotrexate Carton2
This text appears to be a label of a medication called Methotrexate Injection, USP, manufactured by RCl I Fecod Heatcar. The label contains information regarding the lot and expiry date, warnings and cautions, and instructions for use. The medication is sold in a 10mL single-use vial containing 250mg of the active ingredient per 10mL. There is a caution note that the medication is a cytotoxic agent that should be protected from light and discarded if unused.*
FDA Label Image

Methotrexate Carton3

FDA Label Image

Methotrexate Label1

Methotrexate Label1
This is a description of a medical product, which is a 2mL sterile and preservative-free injection. The product is manufactured by Accord Healthcare, Inc., and distributed in a single-use vial. The product label contains a warning to refer to the package insert for full prescribing information, boxed warnings, and administration routes. The batch number is required to be printed in the designated area on the label.*
FDA Label Image

Methotrexate Label2

Methotrexate Label2
This is a description of a sterile and preservative-free medication called Methotrexate. The vial contains 250 mg of medication and sodium chloride at 0.490% wv is present. The medication must be kept at 20 to 25°C and protected from light. The vial should be discarded after single use. The manufacturing company is Intas Pharmaceuticals Limited in India, and it is manufactured for Accord Healthcare in Durham, NC. Full prescribing information can be found on the package insert.*
FDA Label Image

Methotrexate Label3

Methotrexate Label3
This is the product label for Sterle, a preservative-free solution of Methotrexate injection. It is available in vials containing 1g of Methotrexate sodium chloride solution per 40ml for intravenous use only. The solution is adjusted to pH 7.4 with Sodium Hydroxide and Hydrochloric Acid. The product has to be stored between 20°C to 25°C and protected from light. Discard the unused portion of the vial. The product is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India, and requires a prescription.*
FDA Label Image

Methotrexate Structure

Methotrexate Structure
This text is not available for generating a useful description as it is a chemical formula for a carboxyl group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.